Type:Notice
Citation:90 FR 8303
Reading Time:about a minute or two
Vici Health Sciences, LLC has applied to become an importer of specific controlled substances to support their research and clinical trials. The Drug Enforcement Administration (DEA) is accepting public comments and objections to this application until February 27, 2025. Interested parties can submit their comments electronically through the Federal eRulemaking Portal. The DEA has specified that this permit will not authorize the import of finished medication forms for sale.
Simple Explanation
Vici Health Sciences wants permission to bring certain special medicines into the country for research, but you can't buy these as regular medicine. The government is listening to people's opinions on this until February 28, 2025.